Cepheid has supported TB testing worldwide for over 15 years. Xpert MTB/RIF, released in 2009 in collaboration with the Foundation for Innovative New Diagnostics (FIND), was a first-of-its-kind ...

SUNNYVALE, Calif., Oct. 28, 2025 /PRNewswire/ -- Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a new ...

NEW YORK – Danaher subsidiary Cepheid announced Tuesday that its Xpert MTB/XDR test for tuberculosis drug resistance has been awarded prequalification status by the World Health Organization. The ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Between Nov 19 and Dec 3, 2020, 114 clinics were screened, of which 29 were randomly assigned and ...

ABSTRACT: Background: Diagnosing paediatric tuberculosis (TB) remains challenging, partly because they are often unable to produce sputum samples. The use of stool samples with the Xpert MTB/RIF Ultra ...

WHO recommends Xpert MTB/RIF Ultra (Ultra) for stool testing for tuberculosis diagnosis in children. Stool processing requires removal of debris and PCR inhibitors, frequently by using centrifugation, ...

Background: The identification of non-tuberculosis (TB) mycobacterial (NTM) infection remains a significant challenge. This study aims to investigate the diagnostic value of multicolour nested ...

INTRODUCTION: Gene-Xpert MTB RIF (Xpert) is based on nucleic acid amplification by real-time polymerase chain reaction, which allows for the identification of Mycobacterium tuberculosis and rifampin ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB). The ULTR-AI ...

The ULTR-AI suite analyses images from portable, smartphone-connected ultrasound devices, offering a sputum-free, rapid, and scalable alternative for TB detection. The results exceed the World Health ...